Journal article 441 views
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial
Yasmin Abu‐Ghanem ,
Johannes V. van Thienen,
Christian Blank,
Maureen J. B. Aarts,
Michael Jewett,
Igle Jan de Jong,
Jean‐Baptiste Lattouf,
Harm H. E. van Melick,
Lori Wood,
Peter Mulders,
Sylvie Rottey,
John Wagstaff,
Patricia Zondervan,
Tom Powles,
Anouk Neven,
Laurence Collette,
Bertrand Tombal ,
John Haanen,
Axel Bex
BJU International, Volume: 130, Issue: 1, Pages: 68 - 75
Swansea University Author: John Wagstaff
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1111/bju.15625
Abstract
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial
Published in: | BJU International |
---|---|
ISSN: | 1464-4096 1464-410X |
Published: |
Wiley
2022
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa58566 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2021-11-08T09:54:24Z |
---|---|
last_indexed |
2023-01-11T14:39:15Z |
id |
cronfa58566 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2022-07-25T13:54:39.9971688</datestamp><bib-version>v2</bib-version><id>58566</id><entry>2021-11-08</entry><title>Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial</title><swanseaauthors><author><sid>fdab5e9e2fe06c93d3ffa19c816bdcf6</sid><firstname>John</firstname><surname>Wagstaff</surname><name>John Wagstaff</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-11-08</date><deptcode>SGMED</deptcode><abstract/><type>Journal Article</type><journal>BJU International</journal><volume>130</volume><journalNumber>1</journalNumber><paginationStart>68</paginationStart><paginationEnd>75</paginationEnd><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1464-4096</issnPrint><issnElectronic>1464-410X</issnElectronic><keywords>cytoreductive nephrectomy; deferred; immediate; renal cell carcinoma; sunitinib; survival; #uroonc; #kcsm; #KidneyCancer</keywords><publishedDay>1</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-07-01</publishedDate><doi>10.1111/bju.15625</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School - School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>SGMED</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-07-25T13:54:39.9971688</lastEdited><Created>2021-11-08T09:49:09.8027952</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Yasmin</firstname><surname>Abu‐Ghanem</surname><orcid>0000-0003-3682-5963</orcid><order>1</order></author><author><firstname>Johannes V. van</firstname><surname>Thienen</surname><order>2</order></author><author><firstname>Christian</firstname><surname>Blank</surname><order>3</order></author><author><firstname>Maureen J. B.</firstname><surname>Aarts</surname><order>4</order></author><author><firstname>Michael</firstname><surname>Jewett</surname><order>5</order></author><author><firstname>Igle Jan de</firstname><surname>Jong</surname><order>6</order></author><author><firstname>Jean‐Baptiste</firstname><surname>Lattouf</surname><order>7</order></author><author><firstname>Harm H. E. van</firstname><surname>Melick</surname><order>8</order></author><author><firstname>Lori</firstname><surname>Wood</surname><order>9</order></author><author><firstname>Peter</firstname><surname>Mulders</surname><order>10</order></author><author><firstname>Sylvie</firstname><surname>Rottey</surname><order>11</order></author><author><firstname>John</firstname><surname>Wagstaff</surname><order>12</order></author><author><firstname>Patricia</firstname><surname>Zondervan</surname><order>13</order></author><author><firstname>Tom</firstname><surname>Powles</surname><order>14</order></author><author><firstname>Anouk</firstname><surname>Neven</surname><order>15</order></author><author><firstname>Laurence</firstname><surname>Collette</surname><order>16</order></author><author><firstname>Bertrand</firstname><surname>Tombal</surname><orcid>0000-0002-0093-8408</orcid><order>17</order></author><author><firstname>John</firstname><surname>Haanen</surname><order>18</order></author><author><firstname>Axel</firstname><surname>Bex</surname><order>19</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
2022-07-25T13:54:39.9971688 v2 58566 2021-11-08 Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial fdab5e9e2fe06c93d3ffa19c816bdcf6 John Wagstaff John Wagstaff true false 2021-11-08 SGMED Journal Article BJU International 130 1 68 75 Wiley 1464-4096 1464-410X cytoreductive nephrectomy; deferred; immediate; renal cell carcinoma; sunitinib; survival; #uroonc; #kcsm; #KidneyCancer 1 7 2022 2022-07-01 10.1111/bju.15625 COLLEGE NANME Medical School - School COLLEGE CODE SGMED Swansea University 2022-07-25T13:54:39.9971688 2021-11-08T09:49:09.8027952 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Yasmin Abu‐Ghanem 0000-0003-3682-5963 1 Johannes V. van Thienen 2 Christian Blank 3 Maureen J. B. Aarts 4 Michael Jewett 5 Igle Jan de Jong 6 Jean‐Baptiste Lattouf 7 Harm H. E. van Melick 8 Lori Wood 9 Peter Mulders 10 Sylvie Rottey 11 John Wagstaff 12 Patricia Zondervan 13 Tom Powles 14 Anouk Neven 15 Laurence Collette 16 Bertrand Tombal 0000-0002-0093-8408 17 John Haanen 18 Axel Bex 19 |
title |
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial |
spellingShingle |
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial John Wagstaff |
title_short |
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial |
title_full |
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial |
title_fullStr |
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial |
title_full_unstemmed |
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial |
title_sort |
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial |
author_id_str_mv |
fdab5e9e2fe06c93d3ffa19c816bdcf6 |
author_id_fullname_str_mv |
fdab5e9e2fe06c93d3ffa19c816bdcf6_***_John Wagstaff |
author |
John Wagstaff |
author2 |
Yasmin Abu‐Ghanem Johannes V. van Thienen Christian Blank Maureen J. B. Aarts Michael Jewett Igle Jan de Jong Jean‐Baptiste Lattouf Harm H. E. van Melick Lori Wood Peter Mulders Sylvie Rottey John Wagstaff Patricia Zondervan Tom Powles Anouk Neven Laurence Collette Bertrand Tombal John Haanen Axel Bex |
format |
Journal article |
container_title |
BJU International |
container_volume |
130 |
container_issue |
1 |
container_start_page |
68 |
publishDate |
2022 |
institution |
Swansea University |
issn |
1464-4096 1464-410X |
doi_str_mv |
10.1111/bju.15625 |
publisher |
Wiley |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
0 |
active_str |
0 |
published_date |
2022-07-01T04:15:11Z |
_version_ |
1763754022698745856 |
score |
11.03559 |